B cell depleting agent for the treatment of atherosclerosis
US12144859B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 16, 2020 |
| Grant date | Nov 19, 2024 |
| Priority date | — |
| Expiry date | Aug 12, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the prevention or treatment of atherosclerosis, in particular to a B cell depleting agent for the prevention or treatment of atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.